# Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women

> **NCT06970405** · PHASE1 · WITHDRAWN · sponsor: **Regeneron Pharmaceuticals**

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Garetosmab
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT06970405
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-05-29
- **Primary completion:** 2026-06-08
- **Final completion:** 2026-06-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06970405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06970405, "Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06970405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*